Therapy-related AML after lung cancer is rare, but is associated with poor prognosis.
Although other flow cytometry–based prognostic scores have been proposed in the setting of MDS, their complexity has limited their clinical use.
Electronic medical records for more than 3500 survivors of pediatric malignancies were reviewed to determine number for whom cardiomyopathy screenings were recommended and rate of compliance with that recommendation.
Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.
Nearly half of all relapses occurred within the first month of CAR-T infusion.
HCT resulted in a lower risk of death among patients with high risk disease or if performed shortly after diagnosis, according to an observational study.
Two VA medical centers were each awarded one-time $50,000 grant funding to help them enroll veterans with cancer into clinical trials.
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
Three years after expansion, a decrease in late-stage cancers was also detectable.
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
COVID-19 cases on the rise in all but one state.
The approval was based on data from several clinical trials, including the phase 3 PACIFIC trial and the phase 3 CASPIAN trial.
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib.